Royal Bank of Canada’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-505
| Closed | -$2K | – | 7261 |
|
|
2023
Q3 | $2K | Buy |
505
+371
| +277% | +$1.47K | ﹤0.01% | 6343 |
|
|
2023
Q2 | $0 | Buy |
134
+133
| +13,300% | – | ﹤0.01% | 7340 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7129 |
|
|
2022
Q4 | $0 | Sell |
1
-6
| -86% | – | ﹤0.01% | 7428 |
|
|
2022
Q3 | $0 | Buy |
+7
| New | – | ﹤0.01% | 7512 |
|
|
2022
Q2 | – | Sell |
-114
| Closed | -$7K | – | 7379 |
|
|
2022
Q1 | $7K | Sell |
114
-220
| -66% | -$13.5K | ﹤0.01% | 6665 |
|
|
2021
Q4 | $40K | Buy |
334
+169
| +102% | +$20.2K | ﹤0.01% | 5971 |
|
|
2021
Q3 | $23K | Buy |
165
+61
| +59% | +$8.5K | ﹤0.01% | 6124 |
|
|
2021
Q2 | $29K | Buy |
104
+20
| +24% | +$5.58K | ﹤0.01% | 5875 |
|
|
2021
Q1 | $18K | Buy |
84
+30
| +56% | +$6.43K | ﹤0.01% | 5997 |
|
|
2020
Q4 | $13K | Buy |
54
+52
| +2,600% | +$12.5K | ﹤0.01% | 5723 |
|
|
2020
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 6473 |
|
|
2020
Q2 | $0 | Sell |
1
-7
| -88% | – | ﹤0.01% | 6428 |
|
|
2020
Q1 | $0 | Sell |
8
-59
| -88% | – | ﹤0.01% | 6418 |
|
|
2019
Q4 | $5K | Buy |
67
+58
| +644% | +$4.33K | ﹤0.01% | 5772 |
|
|
2019
Q3 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 5879 |
|
|
2019
Q1 | – | Sell |
-3
| Closed | -$1K | – | 6015 |
|
|
2018
Q4 | $1K | Sell |
3
-8
| -73% | -$2.67K | ﹤0.01% | 5709 |
|
|
2018
Q3 | $3K | Buy |
11
+10
| +1,000% | +$2.73K | ﹤0.01% | 5845 |
|
|
2018
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6146 |
|